第一单位：
Unit of Melanoma and Innovative Therapies, IRCCS Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy.
作者：
Paolo A,Ascierto [1]
;
Anna M,Di Giacomo [2]
;
Vanna,Chiarion Sileni [3]
;
Paola,Queirolo [4]
;
Francesco,Spagnolo [5]
;
Federica,De Galitiis [6]
;
Francesco,Cognetti [7]
;
Mario,Mandalà [8]
;
Massimo,Guidoboni [9]
;
Gaetana,Rinaldi [10]
;
Roberta,Depenni [11]
;
Francesca,Consoli [12]
;
Teresa,Troiani [13]
;
Michele,Guida [14]
;
Riccardo,Marconcini [15]
;
Pier F,Ferrucci [16]
;
Sabino,Strippoli [14]
;
Paolo,Fava [17]
;
Barbara,Merelli [18]
;
Ester,Simeone [1]
;
Lorenza,Di Guardo [19]
;
Diana,Giannarelli [20]
;
Massimo,Maio [2]
;
Pietro,Quaglino [21]
;
Michele,Del Vecchio [19]
作者单位：
Unit of Melanoma and Innovative Therapies, IRCCS Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy.
[1]
University of Siena and Center for Immuno-Oncology, University Hospital Le Scotte, Siena, Italy.
[2]
Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
[3]
Division of Melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milano, Italy; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università degli Studi di Genova, Genova, Italy.
[4]
IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università degli Studi di Genova, Genova, Italy.
[5]
Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy.
[6]
Regina Elena Institute, Rome, Italy.
[7]
University of Perugia, Perugia, Italy; Ospedale Papa Giovanni XXIII, Bergamo, Italy.
[8]
Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori "Dino Amadori", Meldola, Italy.
[9]
Department of Surgical, Oncological and Oral Sciences, Unità Operativa Complessa Medical Oncology, Policlinico Universitario Paolo Giaccone, Palermo, Italy.
[10]
Department of Oncology and Hematology, Università degli Studi di Modena e Reggio Emilia, Modena, Emilia-Romagna, Italy.
[11]
Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology Unit, University of Brescia, ASST Spedali Civili, Brescia, Italy.
[12]
University of Campania Luigi Vanvitelli, Napoli, Italy.
[13]
Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
[14]
Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
[15]
Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology IRCCS, Milano, Italy.
[16]
Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
[17]
Ospedale Papa Giovanni XXIII, Bergamo, Italy.
[18]
Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
[19]
Biostatistic, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
[20]
Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: pietro.quaglino@unito.it.
[21]
DOI
10.1016/j.ejca.2023.113246
PMID
37549531
发布时间
2023-08-30
换一批
换一批
